We would love to hear your thoughts about our site and services, please take our survey here.
drthomas... thats the problem here as the mm's are pushing buyers up so EHGOS can forward sell their next batch of shares. Most buys are shown as sells at the same time preventing normal pi's selling.
Thanks OilNovice and others.....
I just wanted to make a reality check to those that are new here and spouting £10M M/C by Summer.
We do need further clarity here from the BOD's but my gut feeling is that they have disclosed their salary alone are £600K pa for the 3 Directors. We know 3 x £250K trenches will be required for them. plus 3 x £250K trenches for finalising and paying off the debt.
My only concern as some have pointed out here does the 0.0009p related to all the shares available to EHGOS ? I just hope not.
EHGOS get 555,555,555 shares for £50k and they are selling at @ 0.04 which is 300% profit.
Does this mean ICON only receives £50K for every 555,555,555 shares ? If so then its going to be a while to reach £1.2M to cover our overheads for the year.
Unless again we get huge revenue announcements of which we can cancel the rest of the EHGOS.
Hope this makes sense
Does anyone have any idea if shares are approved at 0.25p , which is currently 3 time higher than todays price, To be used by the company within a period to purchase other sectors that ICON requires and they carry this out soon after the approval date that we see our SP rise imminently ?
It states the shares are at 105% premium at the period they were proposing the conditions for the AGM.
Are BOD going to release Revenues received for Q4 that justifies the rise and maybe more ?
Good post from sep80 on Advfn. copied
What really excite me in this latest RNS are twofold.
1.It states clearly
"importantly we have already booked revenues in excess of the purchase price."
So if ICON bought GSN for £33K and they have already received revenues in excess of this already then ICON must already be earning £33K plus every month ? The deal was done in Sept 2019 and by Oct 2019 they have already received in one month their costs."
2. Add these Revenues into the equation too.
"The contract with MCM is due to be worth a minimum of GBP25,000 a month as soon as they conclude their acquisition of The Tab and we are looking forward to closing more contracts in Q4 which is traditionally a busy and profitable period for the industry"
So we see at least £50K plus each month and generating revenue must be being received already. This alone will re-rate the current M/C never mind the addition £1M plus contracts.
The more I read the more insight of what really is going on behind the scenes.
Still seeing buys shown as sells. I stick to MM's gathering stock. As we speak they are willing to take all of my holding.
Very encouraging knowing we have revenue being generated and other sectors are being expanded. The delayed news and Legacy issues which have now been resolved has given us an opportunity to increase our holdings at this ridiculous low price.
With news imminent and conformation of contracts together with updates ending in Q4 should see us blast back up.
Good resistance now seeing off 0.065, then 0.075 and now 0.08. Should see 0.15p soon followed by 0.2 p to 0.3p on good news. Can happen any time now.
Buying looks healthy, News Due anytime. Has there been news leaking before an RNs ? We are expecting further updates on Russia's deal with OVB ref- Libicore, who the Patent Licence holder is going to be for production and supply.
The news will shoot the SP way north of 35p
Nice Summary for new investors. Also to mention that there is approx only 28.8 % free float as the other percentage is being held by institutions.
Just a waiting advancements of commercial contracts either JV or Buyout for its Patents. This will multiply in an instant with any such news giving no time to buy at the current share price. Top up at these lows is my best advise and sit tight for news imminently
Further announcements from many other countries confirming their Patents rights.
Whilst awaiting US and UK, OVB will be busy negotiating production options with a JV as it clearly stated it wants to become a Manufacturer too. We are expecting news confirming the market strategy plan of all those Countries that are further forward in accepting Libicore supplies. The more Patents approval being announced the closer production needs to start. Manufacturing 100's M dose's needs to commence to fulfil the demands Worldwide. Stock piling needs to commence together with a Mega marketing campaign.
I personally see this too big of a tall order to execute from OVB and therefore a Major Buyout of the Patent is more likely.
This can happen at any time. Still a Bargain if you consider £35M-£50M plus for a worldwide Patent rights in a £BN market.
Major Companies are no doubt in secret discussions at this early stage. Offer at a low value mention than pay £100M plus in the near future.
OVB are in and will be in a commanding position to negotiate favourable terms.
Listen to Podcast today by J Q. £1M contract will shortly be announced followed by many more.
Holiday period over we are now on the case with further contracts. 0.3p -0.5p then 1p
Market Cap is going to re-rate here quickly